Cellular and Molecular Mechanism of Ganoderma (Lingzhi) Against Tumor

  • Yu Sun
  • Lixin SunEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1182)


The anticancer potential of Ganoderma (Lingzhi) and its extracts has been widely demonstrated, including antiproliferative and apoptosis inductive, antimetastatic, antiangiogenic, and multidrug resistance reversional activities, involving a variety of cellular and molecular mechanisms besides antitumor immunology. Intrinsic- and extrinsic-initiated apoptotic pathway in association with cell cycle arresting, telomerase inhibiting, autophagy, and oxidative stress is involved in the antiproliferative and apoptosis inductive activities of Ganoderma and its extracts. The inhibition of tumor cell adhesion, invasion, and migration by Ganoderma and its extracts involves molecular mechanisms such as AP-1, NF-κB, MMP, cadherin, β-integrin, c-Met, FAK, EMT, and so on. Targeting the major pro-angiogenic stimulus, VEGF, and its receptor contributes to the inhibition of tumor angiogenesis by Ganoderma and its extracts. Inhibition against the ATP-dependent transmembrane drug transporter such as P-glycoprotein (P-gp) on the surface of resistant tumor cells to prevent reduction of the intracellular accumulation of anticancer drugs by pumping out the drugs plays an important role in the activities of Ganoderma and its extracts to reverse tumor cell multidrug resistance.


Ganoderma Lingzhi Tumor Cytotoxicity Apoptosis Invasion Migration Angiogenesis Multidrug resistance 


  1. 1.
    Zhang QH, Yu DH, Lin ZB (2000) Study on the antitumor mechanism of Ganoderma lucidum extract (GLE) by serologic pharmacological method. J Beijing Med Univ 32(3):210–213Google Scholar
  2. 2.
    Zhang QH, Lin ZB (1999) Study on antitumor activity and mechanism of Ganoderma polysaccharides B. Chin J Integr Tradit West Med 19(9):544–543Google Scholar
  3. 3.
    Zhang QH, Lin ZB (1999) The antitumor activity of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Lingzhi) (Aphyllophormycetideae) polysaccharides is related to tumor necrosis factor-α and interferon-γ. Int J Med Mushroom 1:207–215CrossRefGoogle Scholar
  4. 4.
    Hu YH, Lin ZB (1999) Effects of polysaccharides isolated from mycelia of Ganoderma lucidum on HL-60 cell apoptosis. Acta Pharm Sin 34(4):268–271Google Scholar
  5. 5.
    Cao QZ, Lin ZB (2004) Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25(6):833–888PubMedPubMedCentralGoogle Scholar
  6. 6.
    Wang PY, Zhu XL, Lin ZB (2012) Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum. Front Pharmacol 3:135PubMedPubMedCentralGoogle Scholar
  7. 7.
    Yue GG, Fung KP, Tse GM, Leung PC, Lau CB (2006) Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med 12(8):777–789PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Shen J, Park HS, Xia YM, Kim GS, Cui SW (2014) The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed human liver carcinoma HepG2 cells. Carbohydr Polym 103:319–324PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Amen YM, Zhu Q, Tran HB, Afifi MS, Halim AF, Ashour A, Mira A, Shimizu K (2016) Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells. J Nat Med 70(3):661–666PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Smina TP, Mathew J, Janardhanan KK (2016) Ganoderma lucidum total triterpenes attenuate DLA induced ascites and EAC induced solid tumours in Swiss albino mice. Cell Mol Biol (Noisy-le-Grand) 62(5):55–59Google Scholar
  11. 11.
    Satria D, Amen Y, Niwa Y, Ashour A, Allam AE, Shimizu K (2018) Lucidumol D, a new lanostane-type triterpene from fruiting bodies of Reishi (Ganoderma lingzhi). Nat Prod Res 33(2):189–195PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Du GH, Wang HX, Yan Z, Liu LY, Chen RY (2017) Anti-tumor target prediction and activity verification of Ganoderma lucidum triterpenoids. Zhongguo Zhong Yao Za Zhi 42(3):517–522PubMedPubMedCentralGoogle Scholar
  13. 13.
    Xie JT, Wang CZ, Wicks S, Yin JJ, Kong J, Li J, Li YC, Yuan CS (2006) Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp Oncol 28(1):25–29PubMedPubMedCentralGoogle Scholar
  14. 14.
    Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M (2002) New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull (Tokyo) 50(6):837–840CrossRefGoogle Scholar
  15. 15.
    Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48(7):1026–1033PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Ruan W, Wei Y, Popovich DG (2015) Distinct responses of cytotoxic Ganoderma lucidum triterpenoids in human carcinoma cells. Phytother Res 29(11):1744–1752PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Zhang J, Chen JM, Wang XX, Xia YM, Cui SW, Li J, Ding ZY (2016) Inhibitor or promoter? The performance of polysaccharides from Ganoderma lucidum on human tumor cells with different p53 statuses. Food Funct 7(4):1872–1875PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Jiang D, Wang L, Zhao T, Zhang Z, Zhang R, Jin J, Cai Y, Wang F (2017) Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells. Oncol Rep 37(1):594–600PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Dai J, Miller MA, Everetts NJ, Wang X, Li P, Li Y, Xu JH, Yao G (2017) Elimination of quiescent slow-cycling cells via reducing quiescence depth by natural compounds purified from Ganoderma lucidum. Oncotarget 8(8):13770–13781PubMedPubMedCentralGoogle Scholar
  20. 20.
    Chung WT, Lee SH, Kim JD, Park YS, Hwang B, Lee SY, Lee HY (2001) Effect of mycelial culture broth of Ganoderma lucidum on the growth characteristics of human cell lines. J Biosci Bioeng 92(6):550–555PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Banjerdpongchai R, Kongtawelert P, Khantamat O, Srisomsap C, Chokchaichamnankit D, Subhasitanont P, Svasti J (2010) Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells. J Hematol Oncol 3:50PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Dias N, Bailly C (2005) Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70(1):1–12PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME (1998) Apoptosis signaling by death receptors. Eur J Biochem 254(3):439–459PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Rao RV, Ellerby HM, Bredesen DE (2004) Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11(4):372–380PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269–290PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147–153PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16(2):139–144PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Li D, Jia YM, Cao PK, Wang W, Liu B, Li YL (2018) Combined effect of 125I and gemcitabine on PANC-1 cells: cellular apoptosis and cell cycle arrest. J Cancer Res Ther 14(7):1476–1481PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13(3):363–373PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Yamaguchi H, Wang HG (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 279(44):45495–45502PubMedCrossRefGoogle Scholar
  31. 31.
    Momoi T (2004) Caspases involved in ER stress-mediated cell death. J Chem Neuroanat 28(1–2):101–105PubMedCrossRefGoogle Scholar
  32. 32.
    Jimbo A, Fujita E, Kouroku Y, Ohnishi J, Inohara N, Kuida K, Sakamaki K, Yonehara S, Momoi T (2003) ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res 283(2):156–166PubMedCrossRefGoogle Scholar
  33. 33.
    Khaw-On P, Pompimon W, Banjerdpongchai R (2018) Apoptosis induction via ATM phosphorylation, cell cycle arrest, and ER stress by goniothalamin and chemodrugs combined effects on breast cancer-derived MDA-MB-231 cells. Biomed Res Int 2018:7049053PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Li CH, Chen PY, Chang UM, Kan LS, Fang WH, Tsai KS, Lin SB (2005) Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci 77(3):252–265PubMedCrossRefGoogle Scholar
  35. 35.
    Liang Z, Yi Y, Guo Y, Wang R, Hu Q, Xiong X (2014) Chemical characterization and antitumor activities of polysaccharide extracted from Ganoderma lucidum. Int J Mol Sci 15(5):9103–9116PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Smina TP, Nitha B, Devasagayam TP, Janardhanan KK (2017) Ganoderma lucidum total triterpenes induce apoptosis in MCF-7 cells and attenuate DMBA induced mammary and skin carcinomas in experimental animals. Mutat Res 813:45–51PubMedCrossRefGoogle Scholar
  37. 37.
    Wu K, Na K, Chen D, Wang Y, Pan H, Wang X (2018) Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. Int J Oncol 53(6):2356–2368PubMedPubMedCentralGoogle Scholar
  38. 38.
    Zheng L, Wong YS, Shao M, Huang S, Wang F, Chen J (2018) Apoptosis induced by 9,11-dehydroergosterol peroxide from Ganoderma lucidum mycelium in human malignant melanoma cells is Mcl-1 dependent. Mol Med Rep 18(1):938–944PubMedPubMedCentralGoogle Scholar
  39. 39.
    Calviño E, Manjón JL, Sancho P, Tejedor MC, Herráez A, Diez JC (2010) Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk. J Ethnopharmacol 128(1):71–78PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Jang KJ, Han MH, Lee BH, Kim BW, Kim CH, Yoon HM, Choi YH (2010) Induction of apoptosis by ethanol extracts of Ganoderma lucidum in human gastric carcinoma cells. J Acupunct Meridian Stud 3(1):24–31PubMedCrossRefGoogle Scholar
  41. 41.
    Shostak A (2017) Circadian clock, cell division, and cancer: from molecules to organism. Int J Mol Sci 18(4):pii: E873CrossRefGoogle Scholar
  42. 42.
    Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3):153–166PubMedCrossRefGoogle Scholar
  43. 43.
    Mills CC, Kolb EA, Sampson VB (2017) Recent advances of cell-cycle inhibitor therapies for pediatric cancer. Cancer Res 77(23):6489–6498PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Malumbres M (2014) Cyclin-dependent kinases. Genome Biol 15(6):122PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Müller CI, Kumagai T, O’Kelly J, Seeram NP, Heber D, Koeffler HP (2006) Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30(7):841–848PubMedCrossRefGoogle Scholar
  46. 46.
    Zhu HS, Yang XL, Wang LB, Zhao DX, Chen L (2000) Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16(3):201–206PubMedCrossRefGoogle Scholar
  47. 47.
    Lin SB, Li CH, Lee SS, Kan LS (2003) Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72(21):2381–2390PubMedCrossRefGoogle Scholar
  48. 48.
    Hu H, Ahn NS, Yang X, Lee YS, Kang KS (2002) Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102(3):250–253PubMedCrossRefGoogle Scholar
  49. 49.
    Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB (2006) Ganoderiol F, aganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 79(12):1129–1139PubMedCrossRefGoogle Scholar
  50. 50.
    Kuo HP, Hsu SC, Ou CC, Li JW, Tseng HH, Chuang TC, Liu JY, Chen SJ, Su MH, Cheng YC, Chou WY, Kao MC (2013) Ganoderma tsugae extract inhibits growth of HER2-overexpressing cancer cells via modulation of HER2/PI3K/Akt signaling pathway. Evid Based Complement Alternat Med 2013:219472PubMedPubMedCentralGoogle Scholar
  51. 51.
    Sun Z, Huang K, Fu X, Zhou Z, Cui Y, Li H (2014) A chemically sulfated polysaccharide derived from Ganoderma lucidum induces mitochondrial-mediated apoptosis in human osteosarcoma MG63 cells. Tumour Biol 35(10):9919–9926PubMedCrossRefGoogle Scholar
  52. 52.
    Wang T, Xie ZP, Huang ZS, Li H, Wei AY, Di JM, Xiao HJ, Zhang ZG, Cai LH, Tao X, Qi T, Chen DL, Chen J (2015) Total triterpenoids from Ganoderma lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. J Huazhong Univ Sci Technol Med Sci 35(5):736–741PubMedCrossRefGoogle Scholar
  53. 53.
    Shao Y, Qiao L, Wu L, Sun X, Zhu D, Yang G, Zhang X, Mao X, Chen W, Liang W, Zhang Y, Zhang L (2016) Structure identification and anti-cancer pharmacological prediction of triterpenes from Ganoderma lucidum. Molecules 21(5):pii:E678CrossRefGoogle Scholar
  54. 54.
    Na K, Li K, Sang T, Wu K, Wang Y, Wang X (2017) Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo. Int J Oncol 50(5):1541–1554PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Cui ML, Yang HY, He GQ (2017) Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum. J Zhejiang Univ Sci B 18(12):1101–1112PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Gill BS, Navgeet MR, Kumar V, Kumar S (2018) Ganoderic acid, lanostanoid triterpene: a key player in apoptosis. Investig New Drugs 36(1):136–143CrossRefGoogle Scholar
  57. 57.
    Lin TY, Hsu HY, Sun WH, Wu TH, Tsao SM (2017) Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer. Int J Cancer 140(11):2596–2603PubMedCrossRefGoogle Scholar
  58. 58.
    Schrank Z, Khan N, Osude C, Singh S, Miller RJ, Merrick C, Mabel A, Kuckovic A, Puri N (2018) Oligonucleotides targeting telomeres and telomerase in cancer. Molecules 23(9):pii: E2263CrossRefGoogle Scholar
  59. 59.
    Parks JW, Stone MD (2017) Single-molecule studies of telomeres and telomerase. Annu Rev Biophys 46:357–373PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Gonul O, Aydin HH, Kalmis E, Kayalar H, Ozkaya AB, Atay S, Ak H (2015) Effects of Ganoderma lucidum (higher basidiomycetes) extracts on the miRNA profile and telomerase activity of the MCF-7 breast cancer cell line. Int J Med Mushrooms 17(3):231–239PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Liao CH, Hsiao YM, Hsu CP, Lin MY, Wang JC, Huang YL, Ko JL (2006) Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line. Mol Carcinog 45(4):220–229PubMedCrossRefGoogle Scholar
  62. 62.
    Read M, Harrison RJ, Romagnoli B, Tanious FA, Gowan SH, Reszka AP, Wilson WD, Kelland LR, Neidle S (2001) Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci U S A 98(9):4844–4849PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Sillapapongwarakorn S, Yanarojana S, Pinthong D, Thithapandha A, Ungwitayatorn J, Supavilai P (2017) Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity. Bioinformation 13(9):284–292PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Zheng DS, Chen LS (2017) Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens astelomerase inhibitors. Exp Ther Med 14(4):3273–3278PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17(9):528–542PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    White E, Mehnert JM, Chan CS (2015) Autophagy, metabolism, and cancer. Clin Cancer Res 21(22):5037–5046PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM, Chen ZS (2017) Autophagy and multidrug resistance in cancer. Chin J Cancer 36(1):52PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45(6):487–498PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112(12):1809–1820PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Kirkegaard K, Taylor MP, Jackson WT (2004) Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2(4):301–314PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Thyagarajan A, Jedinak A, Nguyen H, Terry C, Baldridge LA, Jiang J, Sliva D (2010) Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 62(5):630–640PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Hahne JC, Meyer SR, Dietl J, Honig A (2014) The effect of cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro. Int J Oncol 45(1):373–382CrossRefGoogle Scholar
  73. 73.
    Oliveira M, Reis FS, Sousa D, Tavares C, Lima RT, Ferreira IC, dos Santos T, Vasconcelos MH (2014) A methanolic extract of Ganoderma lucidum fruiting body inhibits the growth of a gastric cancer cell line and affects cellular autophagy and cell cycle. Food Funct 5(7):1389–1394PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Reis FS, Lima RT, Morales P, Ferreira IC, Vasconcelos MH (2015) Methanolic extract of Ganoderma lucidum induces autophagy of AGS human gastric tumor cells. Molecules 20(10):17872–17882PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Hseu Y-C, Shen Y-C, Kao M-C, Mathew DC, Karuppaiya P, Li M-L, Yang H-L (2019) Ganoderma tsugae induced ROS-independent apoptosis and cytoprotective autophagy in human chronic myeloid leukemia cells. Food Chem Toxicol 124:30–44PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Hsin IL, Ou CC, Wu TC, Jan MS, Wu MF, Chiu LY, Lue KH, Ko JL (2011) GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells. Autophagy 7(8):873–882PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Chiu L-Y, Hu M-E, Yang T-Y, Hsin I-L, Ko J-L, Tsai K-J, Sheu G-T (2015) Immunomodulatory protein from Ganoderma microsporum induces pro-death autophagy through Akt-mTOR-p70S6K pathway inhibition in multidrug resistant lung cancer cells. PLoS One 10(5):e0125774PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Dan X, Liu W, Wong JH, Ng TB (2016) A ribonuclease isolated from wild Ganoderma lucidum suppressed autophagy and triggered apoptosis in colorectal cancer cells. Front Pharmacol 7:213CrossRefGoogle Scholar
  79. 79.
    Mao X, Gu C, Chen D, Yu B, He J (2017) Oxidative stress-induced diseases and tea polyphenols. Oncotarget 8(46):81649–81661PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Silva GÁF, Nunes RAL, Morale MG, Boccardo E, Aguayo F, Termini L (2018) Oxidative stress: therapeutic approaches for cervical cancer treatment. Clinics (Sao Paulo) 73(suppl 1):e548sCrossRefGoogle Scholar
  81. 81.
    Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Banjerdpongchai R, Kongtawelert P, Khantamat O, Srisomsap C, Chokchaichamnankit D, Subhasitanont P, Svasti J (2010) Mitochondrial and endoplasmic reticulum stress pathways cooperate inzearalenone-induced apoptosis of human leukemic cells. J Hematol Oncol 3:50PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Liu RM, Li YB, Liang XF, Liu HZ, Xiao JH, Zhong JJ (2015) Structurally related ganoderic acids induce apoptosis in human cervical cancer HeLa cells: involvement of oxidative stress and antioxidant protective system. Chem Biol Interact 240:134–144PubMedCrossRefGoogle Scholar
  84. 84.
    Kim TH, Kim JS, Kim ZH, Huang RB, Chae YL, Wang RS (2015) Khz (fusion product of Ganoderma lucidum and Polyporus umbellatus mycelia) induces apoptosis in human colon carcinoma HCT-116 cells, accompanied by an increase in reactive oxygen species, activation of caspase 3, and increased intracellular Ca2+. J Med Food 18(3):332–336PubMedCrossRefGoogle Scholar
  85. 85.
    Kim TH, Js K, Kim Z, Huang RB, Wang RS (2012) Khz (fusion of Ganoderma lucidum and Polyporus umbellatus mycelia) induces apoptosis by increasing intracellular calcium levels and activating JNK and NADPH oxidase-dependent generation of reactive oxygen species. PLoS One 7(10):e46208PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Kim TH, Kim JS, Kim ZH, Huang RB, Chae YL, Wang RS (2014) Khz-cp (crude polysaccharide extract obtained from the fusion of Ganoderma lucidum and Polyporus umbellatus mycelia) induces apoptosis by increasing intracellular calcium levels and activating P38 and NADPH oxidase-dependent generation of reactive oxygen species in SNU-1 cells. BMC Complement Altern Med 14:236PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Harhaji Trajković LM, Mijatović SA, Maksimović-Ivanić DD, Stojanović ID, Momcilović MB, Tufegdzić SJ, Maksimović VM, Marjanović ZS, Stosić-Grujicić SD (2009) Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo. Nutr Cancer 61(5):696–703PubMedCrossRefGoogle Scholar
  88. 88.
    Yue QX, Xie FB, Guan SH, Ma C, Yang M, Jiang BH, Liu X, Guo DA (2008) Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci 99(7):1461–1470PubMedCrossRefGoogle Scholar
  89. 89.
    Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr, Ho NW (2002) Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298(4):603–612PubMedCrossRefGoogle Scholar
  90. 90.
    Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, Ho NW (2003) Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9(4):491–493PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Cao QZ, Lin SQ, Wang SZ, Lin ZB (2007) Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro. J Peking Univ (Health Sci) 39(6):653–656Google Scholar
  92. 92.
    Zhao SF, Luo B, Cheng JX (2010) The effects of Ganoderma lucidum spores on invasion and metastasis of human ovarian cancer cells. Chin J Basic Med Tradit Chin Med 16(6):524–526Google Scholar
  93. 93.
    Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D (2006) Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18(4):657–664PubMedPubMedCentralGoogle Scholar
  94. 94.
    Wu GS, Song YL, Yin ZQ, Guo JJ, Wang SP, Zhao WW, Chen XP, Zhang QW, Lu JJ, Wang YT (2013) Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin cascade pathway. PLoS One 8(10):e76620PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Wu QP, Xie YZ, Li SZ, La Pierre DP, Deng Z, Chen Q, Li C, Zhang Z, Guo J, Wong CKA (2006) Tumour cell adhesion and integrin expression affected by Ganoderma lucidum. Enzym Microb Technol 40(1):32–41CrossRefGoogle Scholar
  96. 96.
    Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, Nakshatri H, Sliva D (2014) The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. Int J Oncol 44(6):2009–2015PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Wu JR, Hu CT, You RI, Ma PL, Pan SM, Lee MC, Wu WS (2015) Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways. PLoS One 10(1):e0114495PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Liang ZE, Yi YJ, Guo YT, Wang RC, Hu QL, Xiong XY (2015) Inhibition of migration and induction of apoptosis in LoVo human colon cancer cells by polysaccharides from Ganoderma lucidum. Mol Med Rep 12(5):7629–7636PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Lin TY, Hsu HY (2016) Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Cancer Lett 375(2):340–348PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Li X, Wu Q, Bu M, Hu L, Du WW, Jiao C, Pan H, Sdiri M, Wu N, Xie Y, Yang BB (2016) Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells. Oncotarget 7(23):33948–33959PubMedPubMedCentralGoogle Scholar
  101. 101.
    Li L, Guo HJ, Zhu LY, Zheng L, Liu X (2016) A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial-mesenchymal transition. Phytomedicine 23(5):491–493PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Chen Y, Lv J, Li K, Xu J, Li M, Zhang W, Pang X (2016) Sporoderm-broken Spores of Ganoderma lucidum inhibit the growth of lung cancer: involvement of the Akt/mTOR signaling pathway. Nutr Cancer 68(7):1151–1160PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Tsao SM, Hsu HY (2016) Fucose-containing fraction of Ling-Zhi enhances lipid rafts-dependent ubiquitination of TGFβ receptor degradation and attenuates breast cancer tumorigenesis. Sci Rep 6:36563PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj NJ, Nasti G, Ottaiano A, Berretta M, Iaffaioli RV, Arra C (2017) Anticancer and anti-inflammatory properties of Ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients 9(3):pii: E210CrossRefGoogle Scholar
  105. 105.
    Zhang Y (2017) Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling. Biochem Biophys Res Commun 488(4):679–684PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Li K, Na K, Sang T, Wu K, Wang Y, Wang X (2017) The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo. Oncol Rep 38(5):2803–2813PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W (2018) Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway. Mol Med Rep 17(1):147–153PubMedPubMedCentralGoogle Scholar
  108. 108.
    Qu L, Li S, Zhuo Y, Chen J, Qin X, Guo G (2017) Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells. Oncol Lett 14(6):7467–7472PubMedPubMedCentralGoogle Scholar
  109. 109.
    Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224–S243PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Prager GW, Poettler M (2012) Angiogenesis in cancer. Basic mechanisms and therapeutic advances. Hamostaseologie 32(2):105–114PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78(13):1457–1463PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Kimura Y, Taniguchi M, Baba K (2002) Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22(6A):3309–3318PubMedPubMedCentralGoogle Scholar
  113. 113.
    Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH (2004) Anti-angiogenic and inhibitory activity on inducible nitricoxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 90(1):17–20PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Zhang XC, Chen GL, Ma B, Li XJ, Yu HM (2005) Ganoderma lucidum polysaccharides inhibit angiogenesis and cell adhesion in chicken chorioallantoic membrane model. Basic Clin Med 25(9):825–828Google Scholar
  115. 115.
    Wang XJ, Xu JP, Cheng YF (2006) Inhibitory and antiangiogenetic effects of lucid Ganoderma spore on the human hepatocarcinoma transplanted in nude mice. Acta Academiae Medicinae Xuzhou 26(2):115–119Google Scholar
  116. 116.
    Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC (2009) Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: in vitro and in vivo. Cancer Lett 281(1):108–116PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Guo PR, Sheng YW, Liu B, Wang C, Liu YD, Fu DW, Wang CC (2014) Influence of Ganoderma lucidum polysaccharide on the inhibitory effects of cisplatin on the tumor growth and angiogenesis in bladder cancer (T24) cells-bearing nude mice. Med J Chin PLA 39(6):470–474Google Scholar
  118. 118.
    Dai S, Liu J, Sun X, Wang N (2014) Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43. BMC Complement Altern Med 14:434PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Dewanjee S, Dua TK, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R, Joardar S, Riaz M, Feo V, Zia-Ul-Haq M (2017) Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules 22(6):pii: E871CrossRefGoogle Scholar
  120. 120.
    Li WD, Zhang BD, Wei R, Liu JH, Lin ZB (2008) Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol Sin 29(5):620–623PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Sadava D, Still DW, Mudry RR, Kane SE (2009) Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Lett 277(2):182–189PubMedCrossRefPubMedCentralGoogle Scholar
  122. 122.
    Tang W (2013) Ganoderic acid T improves sensitivity of multidrug resistant KB-A-1/dox cells to doxorubicin. Nat Prod Res Dev 25:1052–1055Google Scholar
  123. 123.
    Tang Y, Gao QH, Xu WT, Wu Z, Li FR (2013) The active section of Ganoderma lucidum on reversion of multidrug resistance in multidrug resistant gastric carcinoma cell line SGC7901/ADR. J Chin Med Mater 36(12):2007–2010Google Scholar
  124. 124.
    Suárez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alviarez DJ, Maldonado-Martinez G, Cubano LA, Martínez-Montemayor MM (2016) Ganoderma lucidum combined with the EGFR tyrosine kinase inhibitor, erlotinib synergize to reduce inflammatory breast cancer progression. J Cancer 7(5):500–511PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Li P, Chen SY, Shen SX, Liu LX, Xu JH, Zhang ZQ (2017) Ethyl lucidenates A reverses P-glycoprotein mediated vincristine resistance in K562/A02 cells. Nat Prod Res 13:1–4Google Scholar
  126. 126.
    Liu DL, Li YJ, Yang DH, Wang CR, Xu J, Yao N, Zhang XQ, Chen ZS, Ye WC, Zhang DM (2015) Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells. Int J Oncol 46(5):2029–2038PubMedCrossRefGoogle Scholar
  127. 127.
    Wu QP, Xie YZ, Deng Z, Li XM, Yang W, Jiao CW, Fang L, Li SZ, Pan HH, Yee AJ, Lee DY, Li C, Zhang Z, Guo J, Yang BB (2012) Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance. PLoS One 7(8):e44579PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Affiliated Hospital of Chengde Medical UniversityChengdeChina

Personalised recommendations